Ovulation induction with clomiphene or gonadotropins

International Congress Series

Volumn 1279, Issue , 2005, Pages 16-23

  Lambalk, C B ^a   Huirne, J A F ^a   Macklon, N S ^b   Fauser, B C J M ^c   Homburg, R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clomiphene; Gonadotropins; Ovulation induction; PCOS

Indexed keywords

EID: 33646439312     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2005.01.009     Document Type: Article

References (34)

1. Wu C.H., and Winkel C.A. The effect of therapy initiation on clomiphene citrate therapy. Fertil. Steril. 52 (1989) 564-568
2. Dickey R.P., et al. Relationship of clomiphene dose and patient weight to successful treatment. Hum. Reprod. 12 (1997) 449-453
3. Gysler M., et al. A decade's experience with an individualized clomiphene treatment regimen including its effects on the postcoital test. Fertil. Steril. 37 (1982) 161-167
4. Imani B., et al. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. J. Clin. Endocrinol. Metab. 83 (1998) 2361-2365
5. Kousta E., White D.M., and Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum. Reprod. 4 (1997) 359-365
6. Homburg R., et al. Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br. Med. J. 297 (1988) 1024-1027
7. Schenker J.G., Jarkoni S., and Granat M. Multiple pregnancies following induction of ovulation. Fertil. Steril. 35 (1981) 105-123
8. Correy J.F., Marsden D.E., and Schokman F.C. The outcome of pregnancy resulting from clomiphene induced ovulation. Aust. N. Z. J. Obstet. Gynaecol. 22 (1982) 18-21
9. Dickey R.P., et al. Incidence of spontaneous abortion in clomiphene pregnancies. Hum. Reprod. 11 (1996) 2623-2628
10. Homburg R., and Insler V. Ovulation induction in perspective. Hum. Reprod. 8 (2002) 449-462
11. Lord J.M., Flight I.H., and Norman R.J. Insulin-sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst. Rev. 3 (2003) (CD003053)
12. Harborne L., et al. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet 361 (2003) 1894-1901
13. Vandermolen D.T., et al. Metformin increases the ovulatory rate and pregnancy rate with clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil. Steril. 75 (2001) 310-315
14. Nestler J.E., et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N. Engl. J. Med. 338 (1998) 1876-1880
15. George S.S., et al. Sequential treatment of metformin and clomiphene citrate in clomiphene resistant women with polycystic ovary syndrome: a randomized, controlled trial. Hum. Reprod. 18 (2003) 299-304
16. Fauser B.C., and Van Heusden A.M. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr. Rev. 18 1 (1997) 71-106
17. Franks S., et al. Mechanism and management of ovulatory failure in women with polycystic ovary syndrome. Hum. Reprod. 3 4 (1988) 531-534
18. White D.M., et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J. Clin. Endocrinol. Metab. 81 (1996) 3821-3824
19. Buvat J., et al. Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil. Steril. 52 (1989) 553-559
20. Shoham Z., Patel A., and Jacobs H.S. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone. Fertil. Steril. 55 (1991) 1051-1056
21. McClure N., et al. Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome?. Fertil. Steril. 58 (1992) 622-624
22. Dale P.O., et al. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum. Reprod. 13 (1998) 567-570
23. Hayden C.J., Rutherford A.J., and Balen A.H. Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon). Fertil. Steril. 71 (1999) 106-108
24. Balasch J., et al. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol. J. Assist. Reprod. Genet. 17 (2000) 561-565
25. Fauser B.C., Donderwinkel P., and Schoot D.C. The step-down principle in gonadotrophin treatment and the role of GnRH analogues. Bailliere's Clin. Obstet. Gynaecol. 7 (1993) 309-330
26. Imani B., et al. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil. Steril. 77 (2002) 83-90
27. Van Santbrink E.J., et al. FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. Eur. J. Endocrinol. 147 (2002) 223-226
28. Van Santbrink E.J., et al. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients. Hum. Reprod. 10 (1995) 1048-1053
29. Van Santbrink E.J., and Fauser B.C. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J. Clin. Endocrinol. Metab. 82 (1997) 3597-3602
30. Hughes E., Collins J., and Vandekerckhove P. Ovulation induction with urinary follicle stimulating hormone vs. human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. The Cochrane Library vol. 3(1) (1996), Update Software, Oxford
31. Yarali H., Bukulmez O., and Gurgan T. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study. Fertil. Steril. 72 (1999) 276-281
32. Coelingh Bennink H.J., Fauser B.C., Out H.J., and the European Puregon Collaborative Anovulation Study Group. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. Fertil. Steril. 69 (1998) 19-25
33. Bayram N., Van Wely M., and Van der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycycstic ovary syndrome. The Cochrane Library (2002), Update Software, Oxford Issue 1
34. Kousta E., et al. Successful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome. Hum. Reprod. 11 (1996) 70-71